Literature DB >> 12447041

Venous malformations of skeletal muscle.

Katherine D Hein1, John B Mulliken, Harry P W Kozakewich, Joseph Upton, Patricia E Burrows.   

Abstract

Intramuscular venous malformations are often mistaken for tumors because of a similar presentation and improper nomenclature. This is a review of 176 patients with venous malformations localized to skeletal muscle compiled from the Vascular Anomalies Center at Children's Hospital from 1980 through 1999. The female-to-male ratio was 2:1. Two-thirds of skeletal muscle venous malformations were noted at birth; the remainder manifested in childhood and adolescence. Venous malformations occurred in every muscle group, most often in the head and neck and extremities. Pain and swelling were the usual presenting complaints. Skeletal problems, such as fracture, deformation, or growth abnormalities, were rare. Hormonal exacerbation and intralesional bleeding were infrequent. Magnetic resonance imaging showed the lesions to be isointense to surrounding muscle on T1-weighted sequences and hyperintense on T2-weighted images. Characteristic tubular or serpentine components were oriented along the muscular long axis. Thrombi were hyperintense on T1-weighted and hypointense on T2-weighted sequences; phleboliths were seen as signal voids on all sequences. Gross examination of resected specimens revealed multicolored tissue with dilated vascular channels, frequently containing phleboliths. Light microscopy showed aggregates of primarily medium-sized, thin-walled vascular channels with flat endothelium and variable smooth muscle, most closely resembling dysplastic veins. Three lesions had a different histologic appearance consisting predominantly of small vessels with capillary structure and proliferative activity admixed with large feeding and draining vessels, similar to a lesion called intramuscular capillary hemangioma in the literature. The endothelium in these three lesions was negative for glucose transporter-1 by immunostaining. Eight percent of the patients, who had minor or no symptoms, were not treated. Twenty-four percent of the patients were managed conservatively (with aspirin and compressive garments); for 17 of these patients (10 percent of 176), noninvasive therapy was not successful, and they proceeded to sclerotherapy, excision, or both. A total of 31 percent of the patients had sclerotherapy, 20 percent had excision, and 27 percent had combined sclerotherapy and excision. Sclerotherapy was used for diffuse lesions, except for those with multiple intralesional thromboses, neurologic impairment, or compressive signs and symptoms. Resection was preferred for venous malformations well localized to a single muscle or muscle group, particularly if the muscles are expendable. Therapeutic outcomes were recorded in the charts or obtained by telephone interview in 122 of the patients (69 percent). Of these, compression garment and aspirin, resection, sclerotherapy, or combined excision and sclerotherapy improved symptoms in 121 patients (92 percent); no change was noted in 10 patients (8 percent). Only one patient was worse (self-reported) after intervention.

Entities:  

Mesh:

Year:  2002        PMID: 12447041     DOI: 10.1097/01.PRS.0000033021.60657.74

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  47 in total

1.  Natural course of venous malformation after conservative treatment.

Authors:  Woo-Sung Yun; Dong-Ik Kim; Young-Nam Rho; Young-Soo Do; Kwang-Bo Park; Keon-Ha Kim; Hong-Suk Park; Young-Wook Kim; Ui-Jun Park; Nari Kim; Shin-Young Woo
Journal:  Surg Today       Date:  2012-04-26       Impact factor: 2.549

2.  PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes.

Authors:  Kyle C Kurek; Emily Howard; L B Tennant; Joseph Upton; Ahmad I Alomari; Patricia E Burrows; Kim Chalache; David J Harris; Cameron C Trenor; Charis Eng; Steven J Fishman; John B Mulliken; Antonio R Perez-Atayde; Harry P W Kozakewich
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

Review 3.  Venous malformation: update on aetiopathogenesis, diagnosis and management.

Authors:  A Dompmartin; M Vikkula; L M Boon
Journal:  Phlebology       Date:  2010-10       Impact factor: 1.740

4.  Ischaemia due to a vascular malformation causing focal myositis.

Authors:  Nuha Marwan Alkhawajah; Tim-Rasmus Kiehl; Vera Bril
Journal:  BMJ Case Rep       Date:  2014-08-25

5.  Primary intra- and juxta-articular vascular malformations of the temporomandibular joint: a clinical analysis of 8 consecutive patients.

Authors:  Qin Zhou; Chi Yang; Min-Jie Chen; Ya-Ting Qiu; Wei-Liu Qiu; Jia-Wei Zheng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

6.  A Vascular Malformation Presenting as a Peripheral Nerve Sheath Tumor.

Authors:  Vikas Parmar; Clayton Haldeman; Steve Amaefuna; Amgad S Hanna
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2016-10-24

Review 7.  Understanding venous malformations of the head and neck: a comprehensive insight.

Authors:  Giacomo Colletti; Anna Maria Ierardi
Journal:  Med Oncol       Date:  2017-02-08       Impact factor: 3.064

8.  A case of vascular malformation of the neck.

Authors:  M Senthilvelan; C Sarath Chandran; C S Subramanian; M Prema; P Umapathi
Journal:  Indian J Surg       Date:  2014-07-23       Impact factor: 0.656

9.  Effect of electrochemotherapy in treating patients with venous malformations.

Authors:  Jing-Hong Li; Yu-Ling Xin; Xue-Qiang Fan; Jie Chen; Jian Wang; Jin Zhou
Journal:  Chin J Integr Med       Date:  2013-03-15       Impact factor: 1.978

10.  Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.

Authors:  Elisa Boscolo; Nisha Limaye; Lan Huang; Kyu-Tae Kang; Julie Soblet; Melanie Uebelhoer; Antonella Mendola; Marjut Natynki; Emmanuel Seront; Sophie Dupont; Jennifer Hammer; Catherine Legrand; Carlo Brugnara; Lauri Eklund; Miikka Vikkula; Joyce Bischoff; Laurence M Boon
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.